Company: GSHRW
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001213900-25-043440
Chunk: 65

Company: Gesher Acquisition Corp. II
Filing Date: 2025-05-14
Form: 10-Q
Item: Part I, Item 8
Chunk 65
---
 if the Company
determines it is desirable to facilitate the completion of the initial Business Combination; (ii) waive their redemption rights with
respect to their founder shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s
amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation
to allow redemption in connection with the initial Business Combination or to redeem 100% of the public shares if the Company has not
consummated an initial Business Combination within the Completion Window or (B) with respect to any other material provisions relating
to shareholders’ rights or pre-initial Business Combination activity; (iii) waive their rights to liquidating distributions
from the Trust Account with respect to their founder shares if the Company fails to complete the initial Business Combination within the
Completion Window, although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares
they hold if the Company fails to complete the initial Business Combination within the Completion Window and to liquidating distributions
from assets outside the Trust Account; and (iv) vote any founder shares held by them and any public shares purchased during or after
the Initial Public Offering (including in open market and privately negotiated transactions) in favor of the initial Business Combination.

Note 5 — Related Party Transactions

Founder Shares

On November 12, 2024, the Sponsor made a
capital contribution of $25,000, or approximately $0.005 per share, through payments of offering costs and expenses on the Company’s
behalf, for which the Company issued 5,513,483 Class B ordinary shares, known as founder shares, to the Sponsor. Up to 622,231 of
the founder shares were subject to surrender by the Sponsor for no consideration depending on the extent to which the underwriters’
over-allotment is exercised. On March 24, 2025, the underwriters exercised their over-allotment option in full as part of the closing
of the Initial Public Offering. As such, the 622,231 founder shares are no longer subject to forfeiture. The Sponsor is holding 5,198,483
founder shares, after giving effect to the founder share interest assignment described below.

On March 5, 2025, the Sponsor granted membership
interests equivalent to an aggregate of 315,000 founder shares to the four independent directors, the chief financial officer (“C